Overview

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness and safety of two different doses of temsirolimus (Torisel).
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Everolimus
Sirolimus